Skip to content
10-Q

Quarterly Report

VivoSim Labs, Inc. VIVS

0000950170-25-022778

← back to feed
Filed
Feb 19, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Feb 1, 2025 17.45M sh
Stockholders Equity Q3 2025 · Dec 31, 2024 $364K
Stockholders Equity Q3 2025 · Mar 31, 2024 $3.6M
Current Liabilities Q3 2025 · Dec 31, 2024 $2.94M
Current Liabilities Q3 2025 · Mar 31, 2024 $1.86M
Total Liabilities Q3 2025 · Dec 31, 2024 $3.48M
Total Liabilities Q3 2025 · Mar 31, 2024 $2.75M
Current Assets Q3 2025 · Dec 31, 2024 $2.1M
Current Assets Q3 2025 · Mar 31, 2024 $3.94M
Total Assets Q3 2025 · Dec 31, 2024 $3.84M
Total Assets Q3 2025 · Mar 31, 2024 $6.35M
Cash And Equivalents Q3 2025 · Mar 31, 2024 $2.9M
Cash And Equivalents Q3 2025 · Dec 31, 2023 $5.3M
Shares Diluted Q3 2025 · Dec 31, 2023 9.12M sh
Shares Diluted Q3 2025 · Dec 31, 2023 8.85M sh
Capex Q3 2025 · Dec 31, 2023 $42K
Operating Cash Flow Q3 2025 · Dec 31, 2023 −$11.98M
Eps Diluted Q3 2025 · Dec 31, 2023 −$0.40
Eps Diluted Q3 2025 · Dec 31, 2023 −$1.31
Eps Basic Q3 2025 · Dec 31, 2023 −$0.40
Eps Basic Q3 2025 · Dec 31, 2023 −$1.31
Sga Expense Q3 2025 · Dec 31, 2023 $2.25M
Sga Expense Q3 2025 · Dec 31, 2023 $7.64M
Rd Expense Q3 2025 · Dec 31, 2023 $1.43M
Rd Expense Q3 2025 · Dec 31, 2023 $4.44M
Net Income Q3 2025 · Dec 31, 2023 −$3.6M
Net Income Q3 2025 · Dec 31, 2023 −$11.63M
Operating Income Q3 2025 · Dec 31, 2023 −$3.68M
Operating Income Q3 2025 · Dec 31, 2023 −$11.99M
Revenue Q3 2025 · Dec 31, 2023 $5K
Revenue Q3 2025 · Dec 31, 2023 $80K